At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 21 enrolled
Drug / intervention
Pimecrolimus 1% creamdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 6-week Randomized, Double-blind, Vehicle-controlled Pilot Study With a 6-week Open Label Extension to Assess the Efficacy and Safety of Pimecrolimus 1% Cream in the Treatment of Oral Lichen Planus
In Brief
A Phase 2 clinical trial evaluating Pimecrolimus 1% cream for Oral Lichen Planus. Completed, enrolled 21 participants across 1 site.
Detailed Summary
Study investigating the use of pimecrolimus 1% cream for oral lichen planus
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOral Lichen Planus
CountriesUnited States
CollaboratorsNovartis
Timeline
Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2005
First PostedFeb 2006
Primary CompletionFeb 2009
TodayJul 2026
First PostedFeb 27, 2006
Enrollment StartAug 1, 2005
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 20.3 years ago
Interventions
Pimecrolimus 1% creamdrug
pimecrolimus cream or matching placebo BID for 6 weeks